CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: PPAR modulator
Accession: CHEBI:70781
browse the term
Definition: Any compound which acts on the peroxisome proliferator-activated receptor.
Synonyms: related_synonym: PPAR modulators; peroxisome proliferator-activated receptor modulator; peroxisome proliferator-activated receptor modulators
xref: PMID:18566691; PMID:19746174; Wikipedia:Peroxisome_proliferator-activated_receptor
G
ACO1
aconitase 1
increases expression
EXP
Clofibrate results in increased expression of ACO1 mRNA
CTD
PMID:17363680
NCBI chr10:33,937,833...34,001,895
Ensembl chr10:33,937,833...34,001,900
G
ACOX1
acyl-CoA oxidase 1
increases expression
EXP
Clofibrate results in increased expression of ACOX1 mRNA
CTD
PMID:16896063 PMID:17437637
NCBI chr12:5,450,913...5,479,550
Ensembl chr12:5,439,361...5,479,546
G
AGT
angiotensinogen
multiple interactions
EXP
Clofibrate inhibits the reaction [AGT protein modified form results in increased expression of EDN1 protein]
CTD
PMID:17105827
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
G
ALB
albumin
decreases expression
EXP
Clofibrate results in decreased expression of ALB mRNA
CTD
PMID:16896063
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
G
BAX
BCL2 associated X, apoptosis regulator
increases expression
EXP
Clofibrate results in increased expression of BAX mRNA
CTD
PMID:17437637
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140
G
BCL2L1
BCL2 like 1
decreases expression
EXP
Clofibrate results in decreased expression of BCL2L1 mRNA
CTD
PMID:17437637
NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694
G
CAT
catalase
increases expression
EXP
Clofibrate results in increased expression of CAT mRNA
CTD
PMID:17437637
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
CPT1A
carnitine palmitoyltransferase 1A
increases expression
EXP
Clofibrate results in increased expression of CPT1A mRNA
CTD
PMID:16896063 PMID:17363680
NCBI chr 2:4,250,642...4,293,914
Ensembl chr 2:4,233,099...4,293,911
G
CTSB
cathepsin B
increases expression
EXP
Clofibrate results in increased expression of CTSB mRNA
CTD
PMID:16896063
NCBI chr14:15,014,139...15,035,081
Ensembl chr14:15,011,711...15,033,877
G
DIO2
iodothyronine deiodinase 2
decreases expression
EXP
Clofibrate results in decreased expression of DIO2 mRNA
CTD
PMID:16896063
NCBI chr 7:103,096,414...103,110,749
Ensembl chr 7:103,096,433...103,323,258
G
EDN1
endothelin 1
decreases expression multiple interactions
EXP
Clofibrate results in decreased expression of EDN1 protein Clofibrate inhibits the reaction [AGT protein modified form results in increased expression of EDN1 protein]; Clofibrate inhibits the reaction [KNG1 protein modified form results in increased expression of EDN1 protein]; Clofibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EDN1 protein]; Nitric Oxide deficiency inhibits the reaction [Clofibrate results in decreased expression of EDN1 protein]
CTD
PMID:17105827
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
G
FABP1
fatty acid binding protein 1
increases expression
EXP
Clofibrate results in increased expression of FABP1 mRNA
CTD
PMID:17363680
NCBI chr 3:57,850,511...57,854,966
Ensembl chr 3:57,850,499...57,854,956
G
GPX1
glutathione peroxidase 1
decreases expression
EXP
Clofibrate results in decreased expression of GPX1 mRNA
CTD
PMID:17437637
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,916,246...31,917,433
G
HMGCS2
3-hydroxy-3-methylglutaryl-CoA synthase 2
increases expression
EXP
Clofibrate results in increased expression of HMGCS2 mRNA
CTD
PMID:17363680
NCBI chr 4:101,420,941...101,440,302
Ensembl chr 4:101,420,872...101,438,126
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Clofibrate results in increased expression of JUN mRNA
CTD
PMID:17437637
NCBI chr 6:153,686,425...153,687,635
Ensembl chr 6:153,685,682...153,687,636
G
KNG1
kininogen 1
multiple interactions
EXP
Clofibrate inhibits the reaction [KNG1 protein modified form results in increased expression of EDN1 protein]
CTD
PMID:17105827
NCBI chr13:124,521,276...124,557,384
Ensembl chr13:124,521,340...124,557,958
G
MYC
MYC proto-oncogene, bHLH transcription factor
increases expression
EXP
Clofibrate results in increased expression of MYC mRNA
CTD
PMID:17437637
NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,122...12,461,078
G
NOS3
nitric oxide synthase 3
increases expression multiple interactions
EXP
Clofibrate results in increased expression of NOS3 protein calphostin C inhibits the reaction [Clofibrate results in increased expression of NOS3 protein]
CTD
PMID:17105827
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
G
PPARA
peroxisome proliferator activated receptor alpha
increases expression multiple interactions
EXP
Clofibrate results in increased expression of PPARA; Clofibrate results in increased expression of PPARA protein calphostin C inhibits the reaction [Clofibrate results in increased expression of PPARA protein]; calphostin C inhibits the reaction [Clofibrate results in increased expression of PPARA]; Tetradecanoylphorbol Acetate inhibits the reaction [Clofibrate results in increased expression of PPARA]
CTD
PMID:17105827 PMID:20568414
NCBI chr 5:3,302,755...3,321,091
Ensembl chr 5:3,300,741...3,364,239
G
SCD
stearoyl-CoA desaturase
increases expression
EXP
Clofibrate results in increased expression of SCD mRNA
CTD
PMID:17363680
NCBI chr14:111,461,560...111,478,033
Ensembl chr14:111,461,569...111,478,020
G
SLC5A5
solute carrier family 5 member 5
increases expression
EXP
Clofibrate results in increased expression of SLC5A5 mRNA
CTD
PMID:16896063
NCBI chr 2:59,869,157...59,885,086
Ensembl chr 2:59,869,155...59,885,266
G
SOD1
superoxide dismutase 1
increases expression
EXP
Clofibrate results in increased expression of SOD1 mRNA
CTD
PMID:17437637
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
G
THRA
thyroid hormone receptor alpha
decreases expression
EXP
Clofibrate results in decreased expression of THRA mRNA
CTD
PMID:16896063
NCBI chr12:22,270,506...22,296,684
Ensembl chr12:22,270,062...22,296,618
G
TNF
tumor necrosis factor
decreases expression
EXP
Clofibrate results in decreased expression of TNF mRNA
CTD
PMID:17437637
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
TPO
thyroid peroxidase
increases expression
EXP
Clofibrate results in increased expression of TPO mRNA
CTD
PMID:16896063
NCBI chr 3:132,384,677...132,409,750
Ensembl chr 3:132,384,583...132,409,208
G
TSHR
thyroid stimulating hormone receptor
increases expression
EXP
Clofibrate results in increased expression of TSHR mRNA
CTD
PMID:16896063
NCBI chr 7:103,768,260...103,925,777
Ensembl chr 7:103,768,296...103,925,922
G
TTR
transthyretin
decreases expression
EXP
Clofibrate results in decreased expression of TTR mRNA
CTD
PMID:16896063
NCBI chr 6:115,496,338...115,503,974
Ensembl chr 6:115,496,326...115,503,977
G
ABCA1
ATP binding cassette subfamily A member 1
increases expression affects localization
EXP
Pioglitazone results in increased expression of ABCA1 mRNA Pioglitazone affects the localization of ABCA1 protein
CTD
PMID:16530456
NCBI chr 1:246,144,277...246,278,492
Ensembl chr 1:246,144,277...246,278,492
G
APOA1
apolipoprotein A1
multiple interactions increases secretion
EXP
Pioglitazone promotes the reaction [APOA1 protein results in increased transport of Cholesterol] Pioglitazone results in increased secretion of APOA1 protein
CTD
PMID:16530456
NCBI chr 9:44,216,481...44,218,360
Ensembl chr 9:44,216,392...44,218,713
G
CLDN3
claudin 3
multiple interactions
EXP
Pioglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN3 protein]
CTD
PMID:36596350
NCBI chr 3:11,019,073...11,020,102
Ensembl chr 3:11,019,073...11,020,102
G
CLDN4
claudin 4
multiple interactions
EXP
Pioglitazone inhibits the reaction [deoxynivalenol results in decreased expression of CLDN4 protein]
CTD
PMID:36596350
NCBI chr 3:11,039,711...11,053,930
Ensembl chr 3:11,039,706...11,053,925
G
LIPG
lipase G, endothelial type
decreases expression
EXP
Pioglitazone results in decreased expression of LIPG mRNA; Pioglitazone results in decreased expression of LIPG protein
CTD
PMID:15953354
NCBI chr 1:99,081,940...99,110,671
Ensembl chr 1:99,081,938...99,110,874
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
EXP
Pioglitazone promotes the reaction [Troglitazone results in increased phosphorylation of MAPK1 protein]
CTD
PMID:17065204
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
EXP
Pioglitazone promotes the reaction [Troglitazone results in increased phosphorylation of MAPK3 protein]
CTD
PMID:17065204
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
PPARG
peroxisome proliferator activated receptor gamma
multiple interactions increases activity
EXP
Troglitazone inhibits the reaction [Pioglitazone results in increased activity of PPARG protein]
CTD
PMID:17065204
NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944
G
SCARB1
scavenger receptor class B member 1
increases expression affects localization
EXP
Pioglitazone results in increased expression of SCARB1 mRNA Pioglitazone affects the localization of SCARB1 protein
CTD
PMID:16530456
NCBI chr14:28,301,421...28,393,568
Ensembl chr14:28,301,294...28,393,568
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all